Avelas Biosciences: Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program
Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program Ambareen Sheriff appointed as Vice President, Regulatory and Quality and Robin Stevens appointed